Medicamen Organics Limited

Medicamen Organics Limited

listed
₹1.28LMin. investment
  1. Bid start
    21 Jun
  2. Bid end
    25 Jun
  3. Allotment
    23 Jun
  4. Release of funds
    27 Jun
  5. Demat transfer
    26 Jun
  6. Listing
    28 Jun

About Medicamen Organics Limited

Price range₹32.00 – ₹34.00
IPO type
SME
Lot size4000 shares
Issue size₹10.54Cr
RHP/DRHP
Read

Checklist

Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

About Medicamen Organics Limited

Medicamen Organics Limited are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer / third party manufacturer.  They distribute their products to private pharmaceutical companies both domestically and internationally via third-party distributors or on a loan license basis. Their products are available across India and in numerous African, CIS, and Southeast Asian countries, including Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, the Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya, thanks to their third-party distribution network.
They have 2 WHO GMP approved manufacturing facilities located at Uttarakhand. Their  manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. Also they have in-house testing laboratory and necessary infrastructure to test raw materials and finished products to match the quality standards.
They are regularly engaged in research and development and launching new products. This gives us an exhaustive product list as well as fair pricing in the market. Their product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).
Business Model:
Contract Manufacturing : Their primary business model is B2B contract manufacturing models where they partner with pharmaceutical companies who are third-party providers who market and sell the products to various companies engaged in ethical marketing as well as generics in International Market and Domestic Markets and has strong and independent sales and distribution networks for the marketing of our products. They have entered into contract manufacturing with 44 domestic partners and 12 merchant exporters.
Government Contract:   They participate in government tenders for supply of the product as per their requirement to government hospitals, government departments, Government PSU, Government armed forces etc. (“Government Contracts”). The advantages of government business include bulk quantity, committed volume, and advantages in purchase price due to high volume. They have served 11 government institution as of March, 2024.
The company is consistent in supplying quality products round the year &  products comply with requisite safety standards. They prioritise the implementation of total quality management techniques. They are a quality conscious company & constantly striving to expand their line of products and are always looking for complementary products that will add to their range of products.
Medicamen Organics Limited Prepares for its Initial Public Offering (IPO), the proceeds generated from the Fresh Issue will be allocated towards crucial objectives:
  1. Funding of expenses proposed to be incurred towards Product registration in the international markets
  2. Plant updation and increase in production capacity
  3. Funding working capital requirements of our Company
  4. General Corporate Purposes.

Frequently asked questions

How to invest in the IPO?

Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Medicamen Organics Limited ?

The issue size of the Medicamen Organics Limited is 10.5399999 Cr.

What is 'pre-apply' for Medicamen Organics Limited ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Medicamen Organics Limited shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.